(R)-N-(4-(3-aminopiperidin-1-yl)-5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)cyclopropanecarboxamide;EOS-62352;GDC0575 hydrochloride;GDC0575 monohydrochloride;GDC0575 monohydrochloride,GDC-0575 monohydrochloride;GDC0575 monohydrochloride, 10 mM in DMSO
GDC0575 (ARRY-575) hydrochloride is a highly selective, orally active Chk1 inhibitor (IC50 = 1.2 nM) used in the study of colitis-associated cancer (CAC) and colitis.